India is experiencing a significant increase in Non-Communicable Diseases (NCDs) such as diabetes, heart disease, cancer, respiratory disorders, mental illness, and pregnancy complications.

These NCDs are the leading causes of reduced life expectancy, accounting for approximately 63% of all deaths in the country. A primary contributor to this rise is the prevalence of inflammation among the population, driven by high consumption of inflammatory Omega-6 fatty acids and a deficiency in anti-inflammatory Omega-3 fatty acids.

Our objective is to restore the right balance of Omega-3 fatty acids in the diet to harness their anti-inflammatory benefits. To address this, we are offering a molecule derived from the plant-based variety of Flaxseed PKVNL 260, renowned for its high Omega content.

This innovative technology was developed at the RWNLF research facility at BVDU in Pune, which holds accreditation from ICAR/NAIP. The entire project is overseen by a team of eminent scientists and researchers, ensuring rigorous scientific oversight and credibility.